Rocket Pharmaceuticals, Inc.

US$2.38As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:RCKTHealthcare
Country USA
PE (Fwd) •••
TSR 9Y CAGR (21.09%)
Div yield —
ROE (4.77%)
Biotechnology
Beta (5Y) 0.49
PE TTM —
TSR TTM (36.74%)
Mkt cap US$261.8M
ROIC (31.03%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$2.53
5.89%
(80.71%)
Hold 5|4|6|12|7
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.02
0.02
0.02
0.02
(2.20%)
(3.37%)
0.66%
(5.88%)
Revenue$M
20.60
20.51
21.12
21.36
(3.23%)
(2.26%)
3.22%
7.56%
Peers (US$261.8M)
Cap (US$)
PE
259.2M
—
Capital
TTM
5Y
10Y
Leveragex
0.965
(0.026)
(0.018)
EBIT/Intx
1.585
0.178
0.200
Own earn%
(57.60)
8.04
7.92
Sh yield%
38.98
30.14
30.03
Owners
Insiders/Inst%
3.64
52.75
Short interest%
2.04
SBC / revenue%
2.98
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
25
Op margin range%
5–10
$1 testx
0.0
Incr. ROIC%
8